Investigations
We examine advertising promises, sales terms and pressure tactics so you can decide without rushing.
10 Day Forecast: FDA found sildenafil and acetaminophen
FDA found undeclared sildenafil and acetaminophen in 10 Day Forecast. See why the agency warns against buying or using it.
LUZE Fit Intensity: FDA finds undeclared sibutramine
FDA testing found undeclared sibutramine in LUZE Fit Intensity. See the warning, known risks, and what buyers should do.
Umary for pain: FDA found three undeclared drugs
FDA found diclofenac, dexamethasone and omeprazole in additional Umary versions. See the warning, risks and what current users should do.
King Kong Honey: FDA found undeclared tadalafil
FDA testing found undeclared tadalafil in Miracle Power of King Kong Honey. What the warning says, who faces added risk and what buyers should do.
Milotox for parasites: two pages, different formulas and an unclear course price
We compared two Kazakhstan-facing Milotox pages: different formulas and directions, one says “free with an order,” another lists 6,990 KZT. Here is what the pages do and do not prove.
InsuLevel: the doctor never gave the promotional interview — SID statement
Italy’s diabetes society debunked a fabricated interview used to promote InsuLevel. What the statement proves, and what it does not.
GlucoWell in Pakistan: Rs 10,900, but where is the proof?
We review the Pakistan GlucoWell offer at Rs 10,900, its diabetes claims, and the evidence the offer does not show.
Coradeluz for high blood pressure: Mexico’s regulator says not to use it
COFEPRIS warned about Coradeluz capsules in Mexico and advised people not to buy or use them. See the claims, ingredient concerns and safer next steps.
Cerebronis in Germany: sellers list different formulas, no product trial shown
Two German Cerebronis pages list different formulas. We check the finished product, ginkgo and St John’s wort claims without unsupported accusations.
Milozol for nail fungus? A foot-care cream is not proven treatment
The affiliate listing promises antifungal action but provides no full formula or trial of finished Milozol. We compare it with a German retail listing and public health guidance.